Gene Regulation by Thiazolidinediones

Completed · Phase 4

Conditions studied: Inflammatory Bowel Disease

In brief

The purpose of this study is to determine the effect of rosiglitazone on the genes of the colon

Key facts

Study ID

NCT00567593

Run by

James Lewis

People needed

12

Starts

2007-10-01

Expected to finish

2008-03-01

Last updated by the study team

2016-08-01

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Capable of giving informed consent
• Agrees to use a barrier method of birth control for the duration of the study

You may not qualify if…

• History of inflammatory bowel disease
• Has taken prescription or over the counter medications in the two weeks prior to enrollment
• History of diabetes, heart failure, angina, hypertension, coronary heart disease, cancer, bleeding disorder, HIV, AIDS
• Fasting LDL >160 mg/dl
• History of smoking in the year prior to enrollment
• Pregnant or breastfeeding

Where it is running

• University of Pennsylvania Clinical and Translational Research Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.